Literature DB >> 7661690

Cell membrane bound N-acetylneuraminic acid is involved in the infection of fibroblasts and phorbol-ester differentiated monocyte-like cells with human cytomegalovirus (HCMV).

P E Lobert1, D Hober, A Dewilde, P Wattré.   

Abstract

We focused on the role of membrane bound sugar residues in the infection of fibroblasts and monocyte-like cells with human cytomegalovirus (HCMV). Treatment of phorbol 12-myristate 13-acetate (PMA) differentiated monocyte-like cells THP-1 or human fibroblasts MRC-5 with lectins specific for N-acetylneuraminic acid (NeuAc) blocked infection with HCMV. HCMV failed to infect sialidase-treated differentiated THP-1 cells or MRC-5 cells. By using NeuAc, N-glycolylneuraminic acid (NeuGl) and alpha 2-3, but not alpha 2-6, sialyl-oligosaccharide, the infection of cells was less efficient. NeuAc was more potent inhibitor than NeuGl. These observations suggest that the sialic acid specificity and the nature of the interglycosidic linkage at the end of the complex carbohydrates may play an important role. Analogous experiments indicated that HCMV binds to N-acetylglucosamine (GlcNAc) in addition to NeuAc. Human cytomegalovirus infection in differentiated THP-1 cells and in human fibroblasts was inhibited by incubation of the virus with 20 micrograms/ml of heparin before and during the adsorption period. Treatment of the cells with heparinase or heparitinase inhibited infection with HCMV. We emphasized the role of NeuAc and GlcNAc and heparan sulfate proteoglycans at the surface of the cells, in the early steps of infection of both human fibroblasts and PMA differentiated monocyte-like cells with HCMV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7661690     DOI: 10.1007/bf01322663

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  46 in total

1.  The human fibroblast receptor for gp86 of human cytomegalovirus is a phosphorylated glycoprotein.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 2.  Human cytomegalovirus glycoprotein-receptor interactions.

Authors:  L Rasmussen; S Resta; T Merigan
Journal:  Transplant Proc       Date:  1991-06       Impact factor: 1.066

3.  Detection of cytomegalovirus by ELISA in urine samples is inhibited by beta 2 microglobulin.

Authors:  J A McKeating; J E Grundy; Z Varghese; P D Griffiths
Journal:  J Med Virol       Date:  1986-04       Impact factor: 2.327

Review 4.  Glycoproteins: what are the sugar chains for?

Authors:  J C Paulson
Journal:  Trends Biochem Sci       Date:  1989-07       Impact factor: 13.807

5.  Cytomegalovirus infection of human blood cells.

Authors:  L Einhorn; A Ost
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

6.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

7.  Selective permissiveness of TPA differentiated THP-1 myelomonocytic cells for human cytomegalovirus strains AD169 and Towne.

Authors:  L W Turtinen; B J Seufzer
Journal:  Microb Pathog       Date:  1994-05       Impact factor: 3.738

8.  Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.

Authors:  M P Cranage; G L Smith; S E Bell; H Hart; C Brown; A T Bankier; P Tomlinson; B G Barrell; T C Minson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope.

Authors:  B Kari; R Gehrz
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Authors:  M P Cranage; T Kouzarides; A T Bankier; S Satchwell; K Weston; P Tomlinson; B Barrell; H Hart; S E Bell; A C Minson
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  2 in total

1.  Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts.

Authors:  P E Lobert; D Hober; A S Delannoy; P Wattré
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 2.  Sialic acids in molecular and cellular interactions.

Authors:  S Kelm; R Schauer
Journal:  Int Rev Cytol       Date:  1997
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.